These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9922334)

  • 1. HCV and C282Y: a sinister synergism?
    Russo M; Grimm IS
    Gastroenterology; 1999 Feb; 116(2):494-5. PubMed ID: 9922334
    [No Abstract]   [Full Text] [Related]  

  • 2. [Iron as comorbid factor in chronic hepatitis C].
    Erhardt A; Hauck K; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):685-91. PubMed ID: 14685669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hemochromatosis genes in chronic hepatitis C.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R; Baldassarre R
    Clin Ter; 2006; 157(1):61-8. PubMed ID: 16669553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C.
    Kazemi-Shirazi L; Datz C; Maier-Dobersberger T; Kaserer K; Hackl F; Polli C; Steindl PE; Penner E; Ferenci P
    Gastroenterology; 1999 Jan; 116(1):127-34. PubMed ID: 9869610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predicting liver fibrosis with non-invasive tests--a hope for the future].
    Marín Gabriel JC; Solís Herruzo JA
    Rev Esp Enferm Dig; 2008 Oct; 100(10):605-10. PubMed ID: 19119784
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron storage disorders of the liver.
    Grace ND; Powell LW
    Gastroenterology; 1974 Dec; 67(6):1257-83. PubMed ID: 4609829
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
    Valenti L; Dongiovanni P; Fargion S; Fracanzani AL
    J Hepatol; 2008 Mar; 48(3):513-4; author reply 514-5. PubMed ID: 18194822
    [No Abstract]   [Full Text] [Related]  

  • 11. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal hemochromatosis: failure of deferoxamine therapy.
    Jonas MM; Kaweblum YA; Fojaco R
    J Pediatr Gastroenterol Nutr; 1987; 6(6):984-8. PubMed ID: 3681586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
    Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
    J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients.
    Loréal O; Deugnier Y; Moirand R; Lauvin L; Guyader D; Jouanolle H; Turlin B; Lescoat G; Brissot P
    J Hepatol; 1992 Sep; 16(1-2):122-7. PubMed ID: 1484146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Thursz M
    Gut; 2007 May; 56(5):613-4. PubMed ID: 17440181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure.
    Fenton H; Torbenson M; Vivekanandan P; Yeh MM; Hart J; Ferrell L
    Transplantation; 2009 Apr; 87(8):1256-60. PubMed ID: 19384175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemochromatosis C282Y mutation and histological fibrosis in patients with C virus chronic hepatitis.
    Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Pawlotsky JM; Zafrani ES; Amslem S; Dhumeaux D
    Hepatology; 1999 Apr; 29(4):1338. PubMed ID: 10336338
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in iron metabolism in chronic hepatitis C].
    Fernández Salazar L; García Buey L; Moreno Otero R
    Rev Esp Enferm Dig; 1999 Aug; 91(8):583-9. PubMed ID: 10491490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.